-
41“…OBJECTIVE: To explore the effect of implantable cardioverter defibrillator/cardiac resynchronization therapy defibrillator (ICD/CRT-D) implantation on adverse events and the readmission rate in patients with chronic heart failure (CHF). METHODS: Sixty patients with CHF treated in our hospital from April 2019 to July 2021 were enrolled. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
42
-
43por Eidizadeh, Abass, Schnelle, Moritz, Leha, Andreas, Edelmann, Frank, Nolte, Kathleen, Werhahn, Stefanie Maria, Binder, Lutz, Wachter, Rolf“…METHODS AND RESULTS: A total of 180 biomarkers in the plasma of a representative subgroup (71 years old) of HFpEF (70% female) with a left ventricular ejection fraction (LVEF) ≥ 50% and HFrEF (18% female) with an LVEF ≤ 40% patients (n = 127) from the Prevalence and Clinical Course of Diastolic Dysfunction and Diastolic Heart Failure (DIAST‐CHF) trial were examined and compared with a healthy control group (n = 40; 48% female). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
44
-
45por Rigolli, Marzia, Cicoira, Mariantonietta, Bergamini, Corinna, Chiampan, Andrea, Rossi, Andrea, Vassanelli, Corrado“…We prospectively studied 131 CHF outpatients on optimal treatment for at least six months. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
46por Oliveira, Mayron F., Zelt, Joel T. J., Jones, Joshua H., Hirai, Daniel M., O'Donnell, Denis E., Verges, Samuel, Neder, J. Alberto“…From a clinical perspective, impaired tissue O(2) transport is a key pathophysiological mechanism shared by cardiopulmonary diseases, such as chronic obstructive pulmonary disease (COPD) and chronic heart failure (CHF). In addition to arterial hypoxemic conditions in COPD, there is growing evidence that cerebral and muscle blood flow and oxygenation can be reduced during exercise in both isolated COPD and CHF. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
47por Pierobon, Antonia, Granata, Nicolò, Torlaschi, Valeria, Vailati, Chiara, Radici, Alice, Maestri, Roberto, Pavesi, Claudia, Sommaruga, Marinella, Gazzi, Lidia, Bertolotti, Giorgio, Sarzi Braga, Simona, Monelli, Mauro, Zanelli, Emanuela, Giardini, Anna“…BACKGROUND: The association among psychological, neuropsychological dysfunctions and functional/clinical variables in Chronic Heart Failure (CHF) has been extensively addressed in literature. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
48por Schumacher, Pia M., Griese-Mammen, Nina, Schneider, Juliana, Laufs, Ulrich, Schulz, Martin“…Aims: Patients with chronic heart failure (CHF) require polypharmacy and are at increased risk for drug-related problems. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
49por Natrus, Larysa, Labudzynskyi, Dmytro, Muzychenko, Petro, Chernovol, Petro, Klys, Yuliia“…In this study, we investigated the effect of healthy donors plasma exosomes (HDPE) on the production of cytokines by PBMC cells of patients with congestive heart failure (CHF) and showed the integral role of miRNA-126 in CHF-mediated changes of mononuclear paracrine secretion. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
50“…However, its utility in noninvasive diagnosis of Chronic heart failure (CHF) has rarely been studied. PURPOSE: In this study, we proposed a method for signal denoising, segmentation, and feature extraction for KS, and a Bayesian optimization-based support vector machine algorithm for KS classification. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
51por Kenealy, Timothy W., Parsons, Matthew J. G., Rouse, A. Paul B., Doughty, Robert N., Sheridan, Nicolette F., Hindmarsh, Jennifer K. Harré, Masson, Sarah C., Rea, Harry H.Enlace del recurso
Publicado 2015
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
52por Stahrenberg, Raoul, Duvinage, André, Mende, Meinhard, Gelbrich, Götz, auf der Heide, Wiebke, Düngen, Hans‐Dirk, Binder, Lutz, Nolte, Kathleen, Herrmann‐Lingen, Christoph, Hasenfuß, Gerd, Pieske, Burkert, Wachter, Rolf, Edelmann, Frank“…METHODS: A cross‐sectional analysis from the prospective cohort programme Prevalence and Clinical Course of Diastolic Dysfunction and Heart Failure (DIAST‐CHF) that included a total of 1937 patients (age, 50–85 years) with >1 risk factor (hypertension, atherosclerotic disease, diabetes mellitus, and obstructive sleep apnoea) was carried out. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
53por Govoni, Mirco, Bassi, Michele, Vezzoli, Stefano, Lucci, Germano, Emirova, Aida, Nandeuil, Marie Anna, Petruzzelli, Stefano, Jellema, Gera L., Afolabi, Ebenezer K., Colgan, Brendan, Leaker, Brian, Kornmann, Oliver, Beeh, Kai Michael, Watz, Henrik, Singh, Dave“…We aimed to characterise the whole genome gene expression profile of the inhaled PDE4-inhibitor CHF6001 on top of triple therapy in sputum cells and whole blood of patients with COPD and chronic bronchitis. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
54por Schulz, Martin, Griese‐Mammen, Nina, Schumacher, Pia M., Anker, Stefan D., Koehler, Friedrich, Ruckes, Christian, Rettig‐Ewen, Volker, Wachter, Rolf, Trenk, Dietmar, Böhm, Michael, Laufs, Ulrich“…The randomized controlled trial PHARM‐CHF investigated whether an interdisciplinary intervention consisting of regular contacts with the community pharmacy and weekly dosing aids improves medication adherence in patients with HF. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
55por Hong, Li-li, Zhao, Yan, Chen, Wei-dong, Yang, Chen-yu, Li, Guo-zhuan, Wang, Hong-song, Cheng, Xiao-yu“…Salsolinol, aconitine, paeoniflorin, and miltrione are equipped with potential characteristics as pharmacodynamic substances for ESZWD in treating CHF-HKYd. Additionally, the constituents of ESZWD in CHF-HKYd rats are different from normal rats, which provided a reference for the selection of subjects for further study.…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
56por Ess, Gabby, Tippett, Ashley, Salazar, Luis W, Reese, Olivia, Ciric, Caroline R, Hussaini, Laila, Begier, Elizabeth, Hubler, Robin, Liu, Qing, Gessner, Bradford J, Lopman, Benjamin, Kamidani, Satoshi, Rouphael, Nadine, Anderson, Evan J, Rostad, Christina A“…METHODS: Adults ≥ 50 years of age hospitalized for Acute Respiratory Infections (ARI) or exacerbations of CHF or COPD in two hospitals in Atlanta, GA during the 2018-2019 and 2019-2020 respiratory seasons were offered enrollment. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
57por Yu, Man, Xiang, Fan, Beyer, Richard P, Farin, Federico M, Bammler, Theo K, Chin, Michael T“…We have previously found that overexpression of CHF1/Hey2 in the myocardium prevents the development of phenylephrine-induced hypertrophy. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
58por Schirger, John A, Chen, Horng H, Slusser, Josh, Hodge, David, Heublein, Denise, Cataliotti, Alessandro, Sandberg, Sharon, Burnett, John CEnlace del recurso
Publicado 2009
Enlace del recurso
Online Artículo Texto -
59por Sivilia, Sandra, Lorenzini, Luca, Giuliani, Alessandro, Gusciglio, Marco, Fernandez, Mercedes, Baldassarro, Vito Antonio, Mangano, Chiara, Ferraro, Luca, Pietrini, Vladimiro, Baroc, Maria Francesca, Viscomi, Arturo R, Ottonello, Simone, Villetti, Gino, Imbimbo, Bruno P, Calzà, Laura, Giardino, Luciana“…Similarly, amyloid plaque burden, microglia activation and aberrant cell cycle events were significantly affected by CHF5074, but not DAPT, treatment. Both CHF5074 and DAPT reduced intraneuronal Aβ content, also increasing Aβ40 and Aβ42 plasma levels. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
60por Mehralian, Hosseinali, Salehi, Shahriar, Moghaddasi, Jafar, Amiri, Masoud, Rafiei, Hossein“…AIM: Quality of life (QOL) can be considered as a quality indicator of health care systems and nurses can play an important role to improve QOL in patients with congestive heart failure (CHF). The aim of this study was to determine the effects of education provided by nurses on the QOL in patients with CHF in home-visit care compared to usual care. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto